Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) traded down 2.4% on Thursday . The company traded as low as $6.40 and last traded at $6.40. 27,323 shares traded hands during mid-day trading, an increase of 63% from the average session volume of 16,783 shares. The stock had previously closed at $6.56.
Fortress Biotech Trading Up 3.1 %
The company has a 50-day moving average of $8.22 and a 200-day moving average of $13.29.
Fortress Biotech Company Profile
Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.
Featured Articles
- Five stocks we like better than Fortress Biotech
- What Investors Need to Know About Upcoming IPOs
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- CD Calculator: Certificate of Deposit Calculator
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Bank Stocks – Best Bank Stocks to Invest In
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
